Create Free Account

By creating account you will get access to hot stocks & personalised emails

Cann Group Ltd

Healthcare AU CAN

0.038AUD
-0.001(2.56%)

Last update at 2024-12-19T04:48:00Z

Day Range

0.040.04
LowHigh

52 Week Range

0.030.14
LowHigh

Fundamentals

  • Previous Close 0.04
  • Market Cap21.44M
  • Volume285626
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-13.47900M
  • Revenue TTM18.36M
  • Revenue Per Share TTM0.04
  • Gross Profit TTM 20.63M
  • Diluted EPS TTM-0.11

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -33.79000M -26.46800M -25.10300M -16.93739M -10.92632M
Minority interest - - - - -
Net income -33.79000M -26.46800M -25.10300M -16.93739M -11.12523M
Selling general administrative 33.19M 25.13M 21.45M 13.85M 12.02M
Selling and marketing expenses - - - - -
Gross profit 13.78M 6.41M 4.25M 0.00652M 1.88M
Reconciled depreciation 11.96M 4.80M 2.63M 2.16M 1.45M
Ebit -29.96100M -24.64000M -20.95200M -16.06836M -10.72741M
Ebitda -18.00100M -19.84300M -18.32100M -13.90835M -9.25209M
Depreciation and amortization 11.96M 4.80M 2.63M 2.16M 1.48M
Non operating income net other - - - - -
Operating income -29.72600M -24.24700M -19.27000M -16.33100M -10.72741M
Other operating expenses -51.26600M -35.87800M -29.42400M -16.64800M 15.01M
Interest expense 3.16M 1.83M 4.15M 0.87M 0.20M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 4.43M 2.22M 0.04M 0.61M 1.45M
Net interest income -3.15800M -1.82800M -4.11000M -0.86903M 1.45M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 9.78M 6.26M 6.70M 1.82M 0.20M
Total revenue 13.78M 6.41M 4.29M 0.65M 2.35M
Total operating expenses 50.36M 35.48M 27.79M 17.29M 14.54M
Cost of revenue - - 0.05M 0.64M 0.47M
Total other income expense net 5.95M 4.43M 2.55M 0.95M -0.19891M
Discontinued operations - - - - -
Net income from continuing ops -33.79000M -26.46800M -25.10300M -16.93739M -10.92632M
Net income applicable to common shares -33.79000M -26.46800M -25.10300M -16.93739M -10.92632M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 92.77M 129.47M 139.66M 101.79M 76.40M
Intangible assets - 0.21M 0.79M 1.39M 0.83M
Earning assets - - - - -
Other current assets 0.35M 2.60M 1.64M 1.90M 0.61M
Total liab 78.93M 70.20M 54.76M 9.92M 15.33M
Total stockholder equity 13.84M 59.26M 84.90M 91.87M 61.07M
Deferred long term liab - - - - -
Other current liab 2.65M 0.43M 0.16M 0.14M 0.96M
Common stock 182.90M 177.37M 169.43M 149.67M 97.14M
Capital stock - 177.37M 169.43M 149.67M 97.14M
Retained earnings -169.47200M -118.23000M -84.44000M -61.16400M -38.20538M
Other liab - 0.14M 0.10M 0.25M -
Good will - - 0.67M 0.66M 0.66M
Other assets - 0.51M 0.09M 0.09M 0.09M
Cash 1.64M 0.77M 1.91M 3.10M 1.55M
Cash and equivalents - 0.77M 1.91M 3.10M 1.55M
Total current liabilities 78.25M 24.39M 11.30M 9.65M 6.49M
Current deferred revenue 0.18M 0.82M 0.81M 0.77M -0.96300M
Net debt 70.91M 60.20M 45.25M -2.42500M 7.77M
Short term debt 72.05M 15.29M 3.80M 0.41M 0.49M
Short long term debt - 15.29M 3.50M - -
Short long term debt total 72.55M 60.97M 47.16M 0.68M 9.32M
Other stockholder equity - -59.13800M -84.98500M -88.50900M -58.93300M
Property plant equipment - 107.40M 118.20M 76.43M 61.95M
Total current assets 16.26M 21.20M 19.17M 22.09M 12.53M
Long term investments - 0.14M 0.74M 1.22M 1.01M
Net tangible assets - 59.05M 83.44M 89.83M 60.25M
Short term investments - - - -0.08500M -0.08484M
Net receivables 4.08M 5.64M 4.16M 4.20M 0.09M
Long term debt - 45.67M 43.36M 0.00000M 8.19M
Inventory 10.19M 12.20M 11.46M 12.89M 10.04M
Accounts payable 3.38M 7.85M 6.52M 8.33M 6.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.41M 0.12M -0.08200M 3.36M 2.14M
Additional paid in capital - - - - -
Common stock total equity - - - - 97.14M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.04M -107.75000M 0.09M -79.61500M 0.09M
Deferred long term asset charges - - - - -
Non current assets total 76.51M 108.26M 120.50M 79.70M 63.87M
Capital lease obligations - - 0.30M 0.68M 1.13M
Long term debt total - 45.67M 43.36M 0.27M 8.84M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.02800M -45.16400M -0.81400M -34.36241M 28.88M
Change to liabilities 1.87M -3.97100M 3.24M 1.19M 3.75M
Total cashflows from investing activities -0.02800M -45.16400M -17.08400M -34.36241M 3.50M
Net borrowings 13.80M 46.48M -0.44700M 7.59M 0.74M
Total cash from financing activities 21.71M 64.41M 39.47M 7.15M 0.74M
Change to operating activities -0.74000M 0.26M -1.05400M -0.11961M -0.58450M
Net income -33.79000M -26.46800M -25.10300M -16.93700M -11.12523M
Change in cash -1.14900M -1.19100M 1.55M -44.83420M -3.17870M
Begin period cash flow 1.91M 3.10M 1.55M 46.39M 49.57M
End period cash flow 0.77M 1.91M 3.10M 1.55M 46.39M
Total cash from operating activities -22.83500M -20.43300M -20.83000M -17.61900M -7.42255M
Issuance of capital stock 7.92M 17.92M 40.20M 8.00M 0.74M
Depreciation 11.60M 4.46M 2.45M 2.16M 1.48M
Other cashflows from investing activities 3.07M 0.00000M -0.81400M 0.00000M 28.88M
Dividends paid - - - - -
Change to inventory -0.46300M 1.44M -2.85200M -6.56400M -1.47804M
Change to account receivables -2.10000M 0.06M -4.10400M 1.02M -1.11544M
Sale purchase of stock 7.92M 17.92M -0.28600M -0.44256M -0.44256M
Other cashflows from financing activities 17.30M 46.48M -0.44700M -0.41066M 0.44M
Change to netincome 0.42M 3.46M 6.42M 1.63M 1.37M
Capital expenditures 3.10M 45.16M 16.27M 34.36M 25.33M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -2.56300M 1.50M -6.95600M -5.54100M 1.61M
Stock based compensation 0.19M 0.74M 0.58M 0.70M -
Other non cash items -0.64500M 1.58M 1.82M -2.84100M 9.48M
Free cash flow -25.93600M -65.59700M -37.10000M -51.98141M -25.32517M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CAN
Cann Group Ltd		 -0.001 2.56% 0.04 - - 1.17 1.54 6.00 -4.2363
AFP
AFT Pharmaceuticals Ltd		 -0.04 1.54% 2.55 25.90 19.08 1.39 3.57 1.61 13.92
LV1
Live Verdure Ltd		 0.02 2.56% 0.80 - - 68.21 49.49 66.86 -5.083
VLS
Vita Life Sciences Ltd		 - -% 1.78 11.12 - 1.34 2.16 0.99 5.71
SNT
Syntara Limited		 0.002 3.23% 0.06 - 20.45 15.25 19.66 6.32 -2.1607

Reports Covered

Stock Research & News

View All

Profile

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe. It also licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.

Cann Group Ltd

262-276 Lorimer Street, Port Melbourne, VIC, Australia, 3207

Key Executives

Name Title Year Born
Mr. Peter Crock M.B.A., MBA Chief Exec. Officer NA
Ms. Deborah Ambrosini B.Com., F.C.A. CFO & Company Sec. 1974
Mr. Shane Duncan Chief Operating Officer NA
Mr. Geoff Aldred Chief Projects & Information Officer NA
Mr. Clive Fanning Head of Investor Relations NA
Mr. Steven Notaro Head of Legal NA
Mr. Peter Koetsier Chief Executive Officer NA
Mr. Steven Notaro BA, J.D. Head of Legal and Regulatory Affairs & Company Secretary NA
Mr. Peter Koetsier Chief Executive Officer NA
Mr. Steven Notaro BA, J.D. Head of Legal and Regulatory Affairs & Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.